David Weldon's CDC Nomination Withdrawn
Analysis based on 11 articles · First reported Mar 13, 2025 · Last updated Mar 13, 2025
The withdrawal of Dave Weldon's nomination for CDC director creates uncertainty in the leadership of the United States — Centers for Disease Control and Prevention, which could affect public health policy and related industries. The event highlights the political challenges in appointing officials with controversial views, potentially impacting investor confidence in the stability of regulatory bodies.
The United States — White House has withdrawn the nomination of Dave Weldon, a former Florida congressman, to lead the United States — Centers for Disease Control and Prevention. The decision came just before his scheduled confirmation hearing before the United States — United States Senate Committee on Health, Education, Labor and Pensions. Sources indicate that Dave Weldon lacked the necessary votes for confirmation due to his past remarks questioning vaccine safety and criticizing the United States — Centers for Disease Control and Prevention. Dave Weldon was considered closely aligned with Robert F. Kennedy Jr., the U.S. health secretary and a prominent anti-vaccine activist. Senator Patty Murray and Senator Bill Cassidy had both raised concerns about Dave Weldon's views. This marks the third Trump administration nominee to withdraw before a confirmation hearing, following Matt Gaetz and Chad Chronister.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard